Contravisory Investment Management, Inc. Horizon Therapeutics Public LTD CO Transaction History

Contravisory Investment Management, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 13, 2022	SELL	$79.4 - $116.36 $323,316 - $473,817	-4,072 Closed	0 $0
Q1 2022 Apr 08, 2022	SELL	$86.42 - $109.81 $25,839 - $32,833	-299 Reduced 6.84%	4,072 $428,000
Q4 2021 Jan 12, 2022	BUY	$98.56 - $119.91 $29,469 - $35,853	299 Added 7.34%	4,371 $471,000
Q2 2021 Jul 14, 2021	BUY	$86.24 - $95.92 $11,642 - $12,949	135 Added 3.43%	4,072 $381,000
Q1 2021 Apr 14, 2021	SELL	$71.83 - $95.48 $28,229 - $37,523	-393 Reduced 9.08%	3,937 $362,000
Q4 2020 Jan 13, 2021	SELL	$67.0 - $84.39 $19,698 - $24,810	-294 Reduced 6.36%	4,330 $317,000
Q1 2020 Apr 09, 2020	SELL	$24.87 - $38.56 $2,760 - $4,280	-111 Reduced 2.34%	4,624 $137,000
Q4 2019 Jan 09, 2020	BUY	$25.43 - $36.67 $120,411 - $173,632	4,735 New	4,735 $171,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Contravisory Investment Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Contravisory Investment Management, Inc. with notifications on news.